Anixa Biosciences, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ANIX Nasdaq 2836 www.anixa.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Anixa Biosciences, Inc.

Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for CAR-T Technology, Further Strengthening its Robust Intellectual Property Portfolio - Apr 14th, 2025 12:00 pm
Is AngioDynamics (ANGO) Outperforming Other Medical Stocks This Year? - Apr 11th, 2025 1:40 pm
ANIX Gets New Patent for Breast Cancer Vaccine Technology, Stock Up - Apr 10th, 2025 1:58 pm
Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for Patent Covering Breast Cancer Vaccine Technology - Apr 9th, 2025 12:00 pm
EXCLUSIVE: Anixa Biosciences Receives Key US Patent Nod For Breast Cancer Vaccine Patent - Apr 9th, 2025 11:45 am
Anixa Biosciences to Present at the Jones Las Vegas Healthcare and Technology Innovation Conference on April 9th - Apr 1st, 2025 12:00 pm
Anixa Biosciences Enters Letter of Intent with VERDI Solutions to Develop Artificial Intelligence-Guided Personalized and Off-the-Shelf Cancer Vaccines - Mar 25th, 2025 12:00 pm
EXCLUSIVE: Anixa Biosciences Inks Letter of Intent with Austria-Based VERDI Solutions To Develop AI-Guided Personalized Cancer Vaccines - Mar 25th, 2025 11:51 am
Anixa Biosciences Receives Notice of Allowance from USPTO for Ovarian Cancer Vaccine - Mar 24th, 2025 12:00 pm
EXCLUSIVE: Anixa Biosciences Poised To Receive US Patent For Ovarian Cancer Vaccine - Mar 24th, 2025 11:46 am
Anixa Biosciences CEO to Present at the 2025 CAGLA NeauxCancer Conference on March 28th - Mar 17th, 2025 12:00 pm
Is Gilead Sciences (GILD) Stock Outpacing Its Medical Peers This Year? - Mar 10th, 2025 1:40 pm
Anixa Biosciences 2025 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties - Mar 10th, 2025 12:30 pm
Anixa Biosciences Announces Chief Development Officer Dr. Pam Garzone to Speak at the Alliance for Cancer Gene Therapy Summit 2025 on March 19th - Mar 3rd, 2025 1:00 pm
Spotlight On February 2025's Promising Penny Stocks - Feb 27th, 2025 5:05 pm
Anixa Biosciences and Moffitt Cancer Center Complete Dosing in Third Cohort in Ovarian Cancer CAR-T Clinical Trial - Feb 26th, 2025 1:00 pm
Anixa Biosciences' Breast Cancer Vaccine was Featured on Fox News' "America Reports" - Feb 25th, 2025 12:30 pm
Anixa Biosciences Featured in Breaking Cancer News Article on Novel CAR-T Therapy for Ovarian Cancer - Feb 24th, 2025 1:00 pm
Is Agenus (AGEN) Stock Outpacing Its Medical Peers This Year? - Feb 21st, 2025 2:40 pm
Anixa Biosciences Announces Approval of Protocol Amendment for Ovarian Cancer CAR-T Clinical Trial - Feb 18th, 2025 1:00 pm